BioPharma Credit (LON:BPCR – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 1 and last traded at GBX 0.97, with a volume of 1882905 shares changing hands. The stock had previously closed at GBX 0.96.
BioPharma Credit Stock Performance
The company has a market capitalization of £10.91 million, a P/E ratio of 0.09 and a beta of 0.22. The firm’s fifty day moving average is GBX 0.94 and its 200 day moving average is GBX 0.92.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Featured Articles
- Five stocks we like better than BioPharma Credit
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
